Renin-angiotensin blockade reduces serum free testosterone in middle-aged men on haemodialysis and correlates with erythropoietin resistance.

Autor: DeLong, Michael, Logan, Joy L, Yong, Kim-Chong, Lien, Yeong-Hau H
Zdroj: Nephrology Dialysis Transplantation; March 2005, Vol. 20 Issue: 3 p585-590, 6p
Abstrakt: There are conflicting reports about the importance of the renin-angiotensin system (RAS) on erythropoietin (Epo) sensitivity in haemodialysis patients, but the role of gender has not been studied specifically. The hypothesis underlying this study is that Epo resistance associated with RAS blockade (RASB) is specific to men and related to drug-induced lowering of circulating testosterone.
Databáze: Supplemental Index